CLINICAL_TRIALS
withdrawal
· 2012-06-21
Clinical Trial Update: BEZ235 Trial in Patients With Advanced Endometrial Carcinoma [Phase 2]
Summary
A Phase 2 trial of BEZ235 in patients with advanced endometrial carcinoma has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Endometrial Cancer | Phase 2 | Status: WITHDRAWN